SEC Form 4 · accession 0001127602-15-024502
BIOCRYST PHARMACEUTICALS INC · BCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Alexander Ingram
Director
Period of report
Aug 5, 2015
Accepted (ET)
Aug 7, 2015 · 5:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882796
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock OptionF1,F2 | $14.88 | Aug 5, 2015 | A | 18,750 | A | Sep 5, 2015 | Aug 5, 2025 | Common Stock | 18,750 | 18,750 | D |
Explanation of responses
- F1Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan (the "Plan").
- F2Vest 1/9 per month over nine months beginning September 5, 2015.